Consultation: Items which should not routinely be prescribed in primary care
NHS England continues to partner with NHS Clinical Commissioners (NHSCC) to support clinical commissioning groups (CCGs) in ensuring that they can use their prescribing resources effectively and deliver best patient outcomes from the medicines that their local population uses. A national public consultation has been launched on proposals to update and review commissioning guidance on eight more products that cost the NHS more than £68 million.
In the majority of cases there are other more effective, safer and/or cheaper alternatives available to the items that NHS England is recommending should not be routinely prescribed in primary care.
The consultation runs from 28 November 2018 until 28 February 2019. Details of public consultation events can be found here. If you would like any further information please email email@example.com.